- Home
- MTCH vs LEGN Comparison
MTCH vs LEGN Comparison
Compare MTCH & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTCH
- LEGN
- Stock Information
- Founded
- MTCH 1986
- LEGN 2014
- Country
- MTCH United States
- LEGN United States
- Employees
- MTCH N/A
- LEGN N/A
- Industry
- MTCH Computer Software: Programming Data Processing
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- MTCH Technology
- LEGN Health Care
- Exchange
- MTCH Nasdaq
- LEGN Nasdaq
- Market Cap
- MTCH 8.2B
- LEGN 6.7B
- IPO Year
- MTCH 2015
- LEGN 2020
- Fundamental
- Price
- MTCH $37.59
- LEGN $34.47
- Analyst Decision
- MTCH Hold
- LEGN Strong Buy
- Analyst Count
- MTCH 16
- LEGN 12
- Target Price
- MTCH $35.44
- LEGN $73.36
- AVG Volume (30 Days)
- MTCH 3.4M
- LEGN 1.1M
- Earning Date
- MTCH 11-05-2025
- LEGN 11-11-2025
- Dividend Yield
- MTCH 2.02%
- LEGN N/A
- EPS Growth
- MTCH N/A
- LEGN N/A
- EPS
- MTCH 2.03
- LEGN N/A
- Revenue
- MTCH $3,450,576,000.00
- LEGN $796,838,000.00
- Revenue This Year
- MTCH $2.43
- LEGN $70.75
- Revenue Next Year
- MTCH $4.49
- LEGN $52.47
- P/E Ratio
- MTCH $18.48
- LEGN N/A
- Revenue Growth
- MTCH N/A
- LEGN 74.75
- 52 Week Low
- MTCH $26.39
- LEGN $27.34
- 52 Week High
- MTCH $39.20
- LEGN $52.15
- Technical
- Relative Strength Index (RSI)
- MTCH 54.84
- LEGN 44.92
- Support Level
- MTCH $37.06
- LEGN $32.70
- Resistance Level
- MTCH $38.35
- LEGN $34.71
- Average True Range (ATR)
- MTCH 0.81
- LEGN 1.21
- MACD
- MTCH -0.18
- LEGN 0.07
- Stochastic Oscillator
- MTCH 45.65
- LEGN 46.90
About MTCH Match Group Inc.
Match Group Inc is a provider of online dating products. The company's portfolio of brands includes Tinder, Hinge, Match, Meetic, OkCupid, Pairs, Plenty Of Fish, Azar, BLK, and more, each built to increase its user's likelihood of connecting with others. The company has four operating segments: Tinder, Hinge, Evergreen and Emerging, and Match Group Asia. The company generates the majority of its revenue from the Tinder segment.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.